Paul Weiss ordered to reveal privileged information from investigation on behalf of bankrupt Chinese medical company
A US court has demanded that Paul Weiss Rifkind Wharton & Garrison hand over privileged information from an internal investigation the law firm oversaw for China Medical Technologies (CMED) to the company’s liquidator.
To read more
Subscribe to Global Restructuring Review
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Restructuring Review experts.